Context Therapeutics Inc (CNTX) Stock Price, Quote, News & History

CNTXNASDAQ
$0.4237
-0.0117-2.69%
At close: Aug 25, 5:00 PM EST
$0.4300
-0.0054-1.24%
Pre-Market: 8:34 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-33.97M
Investing Cash Flow (TTM)
-6.56M
Financing Cash Flow (TTM)
0
Free Cash Flow (TTM)
-40.53M
Capital Expenditure (TTM)
-6.56M
Net Change in Cash (TTM)
-40.53M

Analyst Trends and Forecast

3
Mar
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$3.98M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.02
Earnings Yield % (TTM)
-113.77%
Earnings Yield % (FWD)
-103.11%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.42

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$42.99M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$0.42
Volume / Avg.
7.27K / 2.74M
Day Range
- - -
52 Wk Range
0.40 - 3.62
Market Cap
$39.51M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
35
Short Interest
7.87%
Days to Cover
3.14

About

Sector
Health Care
Industry
Pharmaceuticals
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Context Therapeutics (CNTX) stock?

A

You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Context Therapeutics (CNTX) competitors?

A

There are no as such competitors for Context Therapeutics.

Q

What is the forecast, or price target, for Context Therapeutics (CNTX) stock?

A

Context Therapeutics has a consensus price target of $5.69.

Q

What is the current price for Context Therapeutics (CNTX)?

A

The stock price for Context Therapeutics (NASDAQ: CNTX) is $0.43 last updated August 27, 2026 at 8:34 AM EDT.

Q

Does Context Therapeutics (CNTX) pay a dividend?

A

There are no upcoming dividends for Context Therapeutics.

Q

When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?

A

Context Therapeutics does not have any upcoming earnings scheduled.

Q

Is Context Therapeutics (CNTX) going to split?

A

There is no upcoming split for Context Therapeutics.

Q

What sector and industry does Context Therapeutics (CNTX) operate in?

A

Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.